Abeona Therapeutics (ABEO) Non Operating Income (2011 - 2026)
Abeona Therapeutics (ABEO) reported Non Operating Income of -$6,000 for Q2 2026, compared with $89,000 a year earlier.
Powered by 
Analysis
Abeona Therapeutics (ABEO) Non Operating Income (2011 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Abeona Therapeutics' Non Operating Income came in at $224,000, down 78.4% year-over-year; for FY2025, it came in at $410,000, down 65.7% from FY2024.
- Non Operating Income has a three-year compound annual growth rate of 42.7% (FY2022 to FY2025).
- By year, Non Operating Income came in at $1.19 million in FY2024 (-59.4%), $2.94 million in FY2023 and $141,000 in FY2022.
- The Q2 2026 figure ranks as the lowest quarterly Non Operating Income since Q3 2022.
- Year over year, Non Operating Income gained in two of the last seven quarters, with an average decline of 0.1%.
- The high point for year-over-year Non Operating Income in five years was Q4 2024 (growth of 209.8%); the low point was Q4 2025 (a decline of 92.3%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $50,000 (Q1 2026), $51,000 (Q4 2025) and $129,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | - |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | - |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | -73.00 Mn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 387.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | - |
| 10 | Abeona Therapeutics | 300.44 Mn | -413.52 Mn | 7.20 Mn | -6,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -6,000.00 |
| Mar 31, 2026 | 50,000.00 |
| Dec 31, 2025 | 51,000.00 |
| Sep 30, 2025 | 129,000.00 |
| Jun 30, 2025 | 89,000.00 |
| Mar 31, 2025 | 141,000.00 |
| Dec 31, 2024 | 663,000.00 |
| Sep 30, 2024 | 145,000.00 |
| Jun 30, 2024 | 224,000.00 |
| Mar 31, 2024 | 162,000.00 |
| Dec 31, 2023 | 214,000.00 |
| Sep 30, 2023 | 111,000.00 |
| Jun 30, 2023 | 2.22 Mn |
| Mar 31, 2023 | 403,000.00 |
| Dec 31, 2022 | 277,000.00 |
| Sep 30, 2022 | -19,000.00 |
| Jun 30, 2022 | -118,000.00 |
| Sep 30, 2018 | 497,000.00 |
| Jun 30, 2018 | 314,000.00 |
| Mar 31, 2018 | 153,000.00 |
API Access
Abeona Therapeutics Non Operating Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-operating-income&ticker=ABEO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-operating-income", "ticker": "ABEO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-operating-income&ticker=ABEO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();